Determination of factors affecting overall survival.

<p>Patients overall survival analyses were made between two groups: (A) patients with or without mutations in <i>NLRP</i> genes; (B) patients with or without mutations in <i>TP53</i> genes; (C) patients with tumors that harbored <i>TLR</i> mutations and those without <i>TLR</i> mutations; (D) patients with or without HPV infections; (E) patients with low stage (stage II) or advanced stage (stage III and beyond) tumors; (F) patients of less or more than 56 years old; (G) patients who received no adjuvant therapy, radiotherapy alone or both chemotherapy and radiotherapy.